Toronto Dominion Bank
ONCY

Toronto Dominion Bank’s Oncolytics Biotech ONCY Stock Holding History

Toronto Dominion Bank’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,908
Closed -$9.86K – 2042
2025
Q2 		$9.86K Buy
+12,908
New +$6.84K ﹤0.01% 1635
2024
Q3 		– Sell
-474
Closed -$469 – 1351
2024
Q2 		$469 Buy
+474
New +$516 ﹤0.01% 1267
2024
Q1 		– Sell
-3,554
Closed -$4.8K – 1562
2023
Q4 		$4.8K Buy
+3,554
New +$5.56K ﹤0.01% 1285
2023
Q3 		– Sell
-99
Closed – – 1878
2023
Q2 		$0 Buy
99
+45
+83% +$75 ﹤0.01% 1706
2023
Q1 		$0 Buy
+54
New +$85 ﹤0.01% 1639
2022
Q3 		– Sell
-35,362
Closed -$34K – 1670
2022
Q2 		$34K Buy
+35,362
New +$43K ﹤0.01% 1160
2022
Q1 		– Sell
-5,154
Closed -$7K – 1823
2021
Q4 		$7K Buy
5,154
+3,848
+295% +$7.11K ﹤0.01% 1408
2021
Q3 		$3K Sell
1,306
-1,294
-50% -$2.93K ﹤0.01% 1314
2021
Q2 		$7K Sell
2,600
-19,865
-88% -$60.8K ﹤0.01% 1266
2021
Q1 		$85K Buy
22,465
+14,731
+190% +$44K ﹤0.01% 1171
2020
Q4 		$18K Buy
7,734
+7,413
+2,309% +$17.8K ﹤0.01% 1217
2020
Q3 		$1K Sell
321
-10,138
-97% -$18.6K ﹤0.01% 1191
2020
Q2 		$20K Buy
+10,459
New +$19.7K ﹤0.01% 1107
2020
Q1 		– Sell
-1,924
Closed -$9K – 1389
2019
Q4 		$9K Sell
1,924
-2,576
-57% -$2.91K ﹤0.01% 1245
2019
Q3 		$3K Buy
+4,500
New +$4.58K ﹤0.01% 1359
2019
Q2 		– Sell
-1,032
Closed -$2K – 1668
2019
Q1 		$2K Buy
1,032
+822
+391% +$1.67K ﹤0.01% 1436
2018
Q4 		$0 Sell
210
-49
-19% -$133 ﹤0.01% 1604
2018
Q3 		$1K Buy
259
+49
+23% +$228 ﹤0.01% 1331
2018
Q2 		$1K Buy
+210
New +$1.29K ﹤0.01% 1417

Other funds holding ONCY

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Toronto Dominion Bank's ONCY Position: Q3 2025 in Review

Toronto Dominion Bank sold out of Oncolytics Biotech (ONCY) in Q3 2025, closing a stake of 12,908 shares — an estimated $9.86K sold.

Toronto Dominion Bank first reported a position in ONCY in Q2 2018 and held it in 19 quarters. The position peaked at $85K in Q1 2021. 56 funds tracked by Wall St. Rank hold ONCY as of Q3 2025.

  • Toronto Dominion Bank reported no remaining Oncolytics Biotech position as of Q3 2025 after selling out during the quarter.
  • Toronto Dominion Bank sold 12,908 Oncolytics Biotech shares in Q3 2025, an estimated $9.86K.
  • Toronto Dominion Bank first reported a position in Oncolytics Biotech in Q2 2018 and held it in 19 quarters.
  • Toronto Dominion Bank's Oncolytics Biotech position peaked at $85K in Q1 2021.
  • 56 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2025.

Based on Toronto Dominion Bank's 13F filing for Q3 2025, filed 14 Nov 2025.